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Objective. ,e aim of this study was to examine the relationship between right ventricular (RV) volume and exercise capacity in
adult patients with atrial septal defect (ASD) and to determine the degree of RV dilatation for transcatheter ASD closure.
Background. RV dilatation is an indication of transcatheter ASD closure; however, few studies have reported the clinical sig-
nificance of RV dilatation.Methods. We enrolled 82 consecutive patients (mean age, 49± 18 years; female, 68%) who underwent
cardiac magnetic resonance imaging and symptom-limited cardiopulmonary exercise test before ASD closure. ,e relationship
between RV volume and peak oxygen uptake (VO2) was evaluated. Results. ,e mean RV end-diastolic volume index was
108± 27ml/m2 (range, 46 to 180ml/m2). ,e mean peak VO2 was 24± 7ml/min/kg (range, 14 to 48ml/min/kg), and the mean
predicted peak VO2 was 90± 23%.,ere were significant negative relationships of RV end-diastolic volume index with peak VO2
(r� −0.28, p< 0.01) and predicted peak VO2 (r� −0.29, p< 0.01). ,e cutoff value of RV end-diastolic volume index <80% of
predicted peak VO2 was 120ml/m2, with the sensitivity of 49% and the specificity of 89%. Conclusions. ,ere was a relationship
between RV dilatation and exercise capacity in adult patients with ASD. RV end-diastolic volume index ≥120ml/m2 was related to
the reduction in peak VO2. ,is criterion of RV dilatation may be valuable for the indication of transcatheter ASD closure.
1. Introduction
Atrial septal defect (ASD) is the most common congenital
heart disease with a left-to-right shunt in adults and is rec-
ognized in 7% of all congenital heart diseases [1]. Many
patients with ASD are asymptomatic in adulthood, but a
reduction in exercise capacity and exertional shortness of
breath appear at over 40 years old [2–5]. Currently, trans-
catheter closure is a general therapy for secundumASD [6, 7].
A significant left-to-right shunt causing right ventricular (RV)
dilatation is an accepted indication of ASD closure [8]. Several
studies have reported that transcatheter ASD closure results in
RV remodeling and exercise capacity improvement [9–13].
However, the relationship between RV dilatation and the
reduction in exercise capacity before ASD closure remains
unclear. Furthermore, there is no criterion of RV dilatation
for performing ASD closure. Cardiac magnetic resonance
(CMR) imaging can accurately quantify RV volume.,us, we
hypothesized that RV dilatation evaluated by CMR imaging
was closely related to exercise capacity. ,e aim of this study
was to examine the relationship between RV volume and
exercise capacity in patients with ASD and to determine the
degree of RV dilatation for ASD closure.
2. Methods
2.1. Study Population. We enrolled 82 consecutive adult
patients with secundum ASD who underwent CMR imaging
Hindawi
Journal of Interventional Cardiology
Volume 2020, Article ID 9509105, 5 pages
https://doi.org/10.1155/2020/9509105
and symptom-limited cardiopulmonary exercise test
(CPET) from January 2016 to August 2019 at Okayama
University Hospital. Patient population in this study was
36% of all patients who underwent ASD closure. Indications
for ASD closure were a significant left-to-right shunt, RV
volume overload, and/or clinical symptoms of heart failure
or paradoxical embolism. Patients with severe pulmonary
arterial hypertension who received specificmedications were
excluded. After right heart catheterization was performed
for hemodynamic evaluation such as pulmonary to systemic
flow ratio (Qp/Qs), mean pulmonary artery pressure, cardiac
output, and cardiac index, transcatheter ASD closure was
performed in all patients without any complications using an
Amplatzer septal occluder device (Abbott, Chicago, IL,
USA) or an Occlutech Figulla Flex II device (Occlutech
GmbH, Jena, Germany).
All patients gave written informed consent for the ex-
aminations. ,e study was approved by the ethical com-
mittee of our institution.
2.2. Cardiac Magnetic Resonance Imaging. CMR imaging
studies were performed on a 1.5-T scanner (Siemens AG,
Erlangen, Germany) under electrocardiogram synchroni-
zation before ASD closure. ,e endocardial and epicardial
contours of both ventricles were manually traced on the
short axis end-diastolic and end-systolic phases using
software (Ziostation; Ziosoft, Tokyo, Japan). RV end-dia-
stolic volume, RV end-systolic volume, RV ejection fraction,
left ventricular (LV) end-diastolic volume, and LV end-
systolic volume were evaluated.
2.3. Echocardiography. Transthoracic echocardiography was
performed in all patients before ASD closure. RV end-di-
astolic basal diameter, RV end-diastolic area, and RV end-
systolic area were evaluated in the apical 4-chamber view. To
assess RV function, tricuspid annular plane systolic excur-
sion (TAPSE), tricuspid annular systolic velocity (S), and RV
fractional area change (FAC) were measured. LV end-dia-
stolic diameter, LV end-systolic diameter, and LV ejection
fraction were also measured. ASD diameter was measured by
transesophageal echocardiography.
2.4. Cardiopulmonary Exercise Test. A maximum symptom-
limited CPET was performed using a bicycle ergometer
before ASD closure. ,e workload was increased by
15watts/min. Patients exercised until exhaustion. Oxygen
uptake (VO2), carbon dioxide production (VCO2), and
minute ventilation (VE) were assessed by breath-by-breath
gas analysis. Peak VO2, predicted peak VO2, peak work,
ventilatory equivalent for carbon dioxide (VE/VCO2 slope),
and respiratory exchange ratio were evaluated. Peak VO2
was defined as the highest value recorded during the last
minute of exercise. Predicted peak VO2 was determined by
age and sex.
2.5. Statistical Analysis. Data are presented as mean-
± standard deviation for continuous variables and as
number and percentage for categorical variables. Pearson’s
correlation coefficient was used to assess relationships be-
tween CMR imaging and echocardiographic parameters
with exercise capacity. Linear regression analysis was per-
formed for multivariate analysis. ,e cutoff value of RV
volume for the reduction in exercise capacity was estimated
using receiver operating characteristic curve. Statistical
analysis was performed with JMP version 14.0 (SAS Institute
Inc., Cary, NC, USA), and significance was defined as a value
of p< 0.05.
3. Results
3.1. Patient Characteristics. ,e study population consisted
of 82 patients (female: 68%) with mean age of 49± 18 years.
Patient characteristics are shown in Table 1. ,e majority of
patients had New York Heart Association functional class I.
ASD diameter was 15± 6mm. ,e Qp/Qs was 2.2± 0.8, and
the mean pulmonary artery pressure was 16± 5mmHg.
3.2. Cardiac Magnetic Resonance Imaging and
Echocardiography. CMR imaging and echocardiographic
parameters are summarized in Table 2. CMR imaging
showed RV end-diastolic volume index of 108± 27ml/m2
(range, 46 to 180ml/m2) and RV end-systolic volume index
of 78± 19ml/m2 (range, 34 to 122ml/m2). Echocardiogra-
phy showed RV end-diastolic basal diameter of 46± 6mm,
RV end-diastolic area of 27± 6 cm2, and RV end-systolic
area of 15± 3 cm2. As the parameters of RV function, TAPSE
was 25± 4mm, S was 15± 2 cm/s, and RV FAC was 45± 4%.
3.3. Cardiopulmonary Exercise Test. CPET parameters are
summarized in Table 2. Peak VO2 was 24± 7ml/min/kg
(range, 14 to 48ml/min/kg), and predicted peak VO2 was
90± 23%. Fifty-one patients (62%) had predicted peak
VO2≥ 80%, 30 patients (37%) had predicted peak VO2
60–80%, and one patient (1%) had predicted peak VO2
<60%.
3.4.Relationships ofCardiacMagneticResonance Imagingand
Echocardiography with Cardiopulmonary Exercise Test.
Regarding CMR imaging, the enlargement of RV end-dia-
stolic volume index was related to the reduction in peak VO2
(r� −0.29, p< 0.01) and predicted peak VO2 (r� −0.24,
p � 0.03) (Figure 1). RV ejection fraction was negatively
related to peak VO2 (r� −0.30, p< 0.01). ,ere were no
relationships of LV end-diastolic volume index or LV end-
systolic volume index with exercise capacity (Table 3).
Multivariate linear regression analysis showed that RV end-
diastolic volume index was independently related to the
reduction in peak VO2 (Table 4).
Regarding echocardiography, RV end-diastolic basal
diameter and RV end-diastolic area were related to the
reduction in peak VO2 (r� −0.30, p< 0.01; r� −0.25,
p � 0.03, respectively). TAPSE, S, or RV FAC was not re-
lated to exercise capacity.
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3.5. Degree of Right Ventricular Dilatation. ,e optimal
cutoff value of RV end-diastolic volume index <80% of
predicted peak VO2 was 120ml/m2 (area under the
curve� 0.69), with the sensitivity of 49% and the specificity
of 89%.
4. Discussion
,e major findings of the present study were as follows: (1)
there was a significant negative relationship between RV
end-diastolic volume and exercise capacity in patients with
ASD; (2) RV end-diastolic volume was the independent
factor related to reduced peak VO2; and (3) the cutoff value
of RV end-diastolic volume index for reduced peak VO2 was
120ml/m2. To the best of our knowledge, this study is the
first study to show the relationship between RV dilatation
and the reduction in exercise capacity before ASD closure
and to indicate the criterion of RV dilatation for reduced
peak VO2.
Most patients with ASD have impaired exercise capacity
with age [14, 15]. RV volume overload because of a left-to-
right shunt causes enlargement of the right ventricle, leading
to clinical symptoms such as dyspnea and fatigue. Exercise
capacity depends on the left-to-right shunt and RV volume
overload. RV dilatation may represent a limiting factor.
However, the relationship between RV dilatation and peak
VO2 before ASD closure has not been fully investigated.
Reduced exercise capacity is associated with decreased
LV stroke volume and cardiac output in patients with ASD
[12]. Altered interventricular interaction induced by long-
standing RV volume overload plays a central role in limiting
exercise tolerance [14]. Because of RV dilatation, the in-
terventricular septum bulges paradoxically and encroaches
into LV cavity, impairing LV filling and thus both diastolic
and systolic performance [16–18]. ,is mechanism could
cause decreased cardiac output, leading to reduced peak
VO2. After transcatheter ASD closure, the abolishment of
the left-to-right shunt leads to augmented LV filling by
preload and therefore to increased cardiac output [14]. Many
studies have reported that transcatheter ASD closure results
in a positive RV remodeling and improved exercise capacity
[9–13]. ,e improvement in cardiac form following in-
creased cardiac output is the most likely factor leading to
improved peak VO2 [19]. In this study, cardiac output was
not markedly decreased. It might be compensated by RV
hypercontraction with the dilatation. However, RV end-






r p value r p value
CMR imaging
RV end-diastolic volume index −0.29 <0.01 −0.24 0.03
RV end-systolic volume index 0.05 0.15 0.13 0.23
RV ejection fraction −0.30 <0.01 −0.24 0.03
LV end-diastolic volume index 0.04 0.09 0.03 0.78
LV end-systolic volume index 0.11 0.34 0.03 0.78
Echocardiography
RV basal diameter −0.30 <0.01 −0.09 0.43
RV end-diastolic area −0.25 0.03 −0.09 0.41
RV end-systolic area −0.24 0.03 −0.08 0.47
RV FAC 0.05 0.69 0.02 0.83
TAPSE 0.05 0.66 0.09 0.83
S 0.14 0.21 <0.01 0.94
LV end-diastolic diameter 0.22 0.04 0.02 0.85
LV end-systolic diameter 0.22 0.04 <0.01 0.97
LV ejection fraction 0.08 0.45 0.04 0.27
CMR� cardiac magnetic resonance; FAC� fractional area change; LV� left
ventricular; RV� right ventricular; S� tricuspid annular systolic velocity;
TAPSE� tricuspid annular plane systolic excursion; VO2 � oxygen uptake.
Table 1: Patient characteristics.
Variables
Age (yrs) 49± 18
Female 56 (68%)
Body surface area (m2) 1.6± 0.2
New York Heart Association functional class I 63 (%)
New York Heart Association functional class II 35 (%)
New York Heart Association functional class III 1 (%)
Atrial fibrillation 5 (6%)
Diuretics 11 (13%)
ASD diameter (mm) 15± 6
Qp/Qs 2.2± 0.8
Mean pulmonary artery pressure (mmHg) 16± 5
Cardiac output, (L/min) 4.3± 1.3
Cardiac index, (L/min/m2) 2.7± 0.8
Data are presented as mean± standard deviation or number (%) of patients.
ASD� atrial septal defect; Qp/Qs� pulmonary to systemic flow ratio.
Table 2: CMR imaging, echocardiography, and CPET parameters.
Variables
CMR imaging
RV end-diastolic volume index (ml/m2) 108± 27
RV end-systolic volume index (ml/m2) 78± 19
RV ejection fraction (%) 27± 7
LV end-diastolic volume index (ml/m2) 54± 12
LV end-systolic volume index (ml/m2) 30± 9
Echocardiography
RV end-diastolic basal diameter (mm) 46± 6
RV end-diastolic area (cm2) 27± 6
RV end-systolic area (cm2) 15± 3
RV FAC (%) 45± 4
TAPSE (mm) 25± 4
S (cm/s) 15± 2
LV end-diastolic diameter (mm) 41± 4
LV end-systolic diameter (mm) 26± 4
LV ejection fraction (%) 66± 9
CPTE
Peak oxygen uptake (ml/kg/min) 24± 7
Predicted peak oxygen uptake (%) 90± 23
Peak work (watts) 104± 36
Ventilatory equivalent for carbon dioxide slope 23± 3
Respiratory exchange ratio 1.2± 0.1
Data are presented as mean± standard deviation. CMR� cardiac magnetic
resonance; CPET�cardiopulmonary exercise test; FAC� fractional area
change; LV� left ventricular; RV� right ventricular; S� tricuspid annular
systolic velocity; TAPSE� tricuspid annular plane systolic excursion.
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diastolic volume tended to be negatively related to cardiac
output. Further studies are needed in order to investigate the
relationship between RV dilatation and decreased cardiac
output.
In the present study, RV end-diastolic volume was
evaluated by CMR imaging. CMR imaging can be used to
accurately quantify RV volume, although there are certain
limitations in echocardiography for assessing RV volume
because of the complex anatomy and structure of the right
ventricle. Even three-dimensional echocardiography is in-
adequate [20]. ,ese factors may influence our result that
RV dilatation evaluated by CMR imaging was closely related
to exercise capacity.
,e present study showed that RV ejection fraction was
negatively related to peak VO2. Following Starling’s law of
the heart, the increased preload results in high ventricular
ejection function.,e parameters of RV function such as RV
ejection fraction, TAPSE, S, and RV FAC tend to be elevated
in patients with ASD and are decreased after device closure
[21–23]. ,e degree of RV ejection fraction depends on RV
volume overload. ,erefore, the relationship between RV
ejection fraction and peak VO2 may be induced by RV
volume overload, similar to the relationship with RV
dilatation. With regards to echocardiographic parameters,
TAPSE, S, or RV FAC was not related to exercise capacity.
,e long axis RV function alone such as TAPSE and S and
the radial RV function alone such as RV FAC may be in-
sufficient for the functional assessments.
4.1. Clinical Implications. A significant left-to-right shunt
with RV dilatation or Qp/Qs> 1.5 is indication of trans-
catheter ASD closure [8]. ,e value of Qp/Qs is widely used
for the planning of therapeutic strategies. However, the
clinical significance of RV dilatation, including the rela-
tionship with clinical symptoms, has not been well inves-
tigated. Further, the degree of RV dilatation that requires
transcatheter ASD closure remains unclear. ,e present
study showed that RV dilatation was related to exercise
capacity in asymptomatic or mildly symptomatic patients.
RV end-diastolic volume ≥120ml/m2 predicted the reduc-
tion of peak VO2. Our results support that RV dilatation is
valuable for determining the optimal timing of transcatheter
ASD closure.
4.2. Study Limitations. ,ere are some limitations in the
present study. First, the number of patients was small. Large
studies are required to confirm our findings. Second, ex-
ercise capacity was influenced by several factors, but non-
cardiac factors such as pulmonary function and skeletal
muscle function were not evaluated. ,ird, some patients
with atrial fibrillation were included in this study. ,e
presence of atrial fibrillation might affect exercise capacity.
Finally, the RV ejection fraction value was low compared
with previous studies [24]. ,us, the calculation of RV
ejection fraction might be underestimated in this study.
5. Conclusions
,ere was a relationship between RV dilatation and exercise
capacity in adult patients with ASD. RV end-diastolic vol-



































RV end-diastolic volume index (ml/m2)
Figure 1: Relationships of RV volume with exercise capacity.,ere were significant negative relationships of RV end-diastolic volume index
with peak VO2 and predicted peak VO2. RV� right ventricular; VO2 � oxygen uptake.
Table 4: Multivariate linear regression analysis for peak VO2.
Variables Beta 95% of CI pvalue
RV end-diastolic volume index −0.35 (−0.10, −0.008) 0.02
Mean pulmonary artery
pressure 0.01 (−031, 0.34) 0.91
Cardiac output 0.15 (−0.75, 2.33) 0.31
Qp/Qs 0.20 (−1.05, 4.28) 0.23
ASD diameter −0.05 (−0.37, 0.26) 0.74
RV FAC 0.08 (−0.29, 0.60) 0.51
TAPSE −0.05 (−0.62, 0.45) 0.76
S 0.20 (−0.30, 0.60) 0.16
ASD� atrial septal defect; CI� confidence interval; FAC� fractional area
change; Qp/Qs� pulmonary to systemic flow ratio; RV� right ventricular;
S� tricuspid annular systolic velocity; TAPSE� tricuspid annular plane
systolic excursion; VO2 � oxygen uptake.
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VO2. Our findings suggest that this criterion of RV dilatation
is valuable for the indication of transcatheter ASD closure.
Abbreviations and Acronyms
ASD: Atrial septal defect
CMR: Cardiac magnetic resonance
CPET: Cardiopulmonary exercise test
FAC: Fractional area change
LV: Left ventricular
Qp/Qs: Pulmonary to systemic flow ratio
RV: Right ventricular
S: Tricuspid annular systolic velocity
TAPSE: Tricuspid annular plane systolic excursion
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